Saturday December 16th 2017

Satisfaction with Multiple Sclerosis Care in Daily Practice of Patients without an Immunmodulating Therapy – Results of a Patient Survey (FOLLOW)…

CONCLUSIONS: MS Patients without immunmodulating therapy are generally satisfied with the care given by the physicians and the involved health service provider, but still see room for improvement in MS therapy. Patients’ choice would be an oral therapy with better effectiveness and tolerability.Study Supported by:Disclosure: Dr. Heeschen has received personal compensation for activities with Novartis as an employee. (Source: Neurology)

Excerpt from:  

Satisfaction with Multiple Sclerosis Care in Daily Practice of Patients without an Immunmodulating Therapy – Results of a Patient Survey (FOLLOW)…

Leave a Comment

More from category

MS Activists Celebrate 2017 State Policy Impact
MS Activists Celebrate 2017 State Policy Impact

/About-the-Society/News/MS-Activists-Celebrate-2017-State-Policy-Impact [Read More]

MS Research Program Funding Authorized by President Trump
MS Research Program Funding Authorized by President Trump

/About-the-Society/News/MS-Research-Program-Funding-Authorized-by-Presiden [Read More]

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]